TSC1 and neoplasm: Green et al. showed that the LKB1/AMPK/TSC tumor suppressor axis could lead to a specific inhibition of the mammalian target of rapamycin (mTOR) catalytic activity, inducing 4E-BP1 dephosphorylation, which inhibits the initiation step of mRNA translation.